These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 24295733)
21. Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex. Sato A; Kasai S; Kobayashi T; Takamatsu Y; Hino O; Ikeda K; Mizuguchi M Nat Commun; 2012; 3():1292. PubMed ID: 23250422 [TBL] [Abstract][Full Text] [Related]
22. Hypothesis-driven investigations of diverse pharmacological targets in two mouse models of autism. Rhine MA; Parrott JM; Schultz MN; Kazdoba TM; Crawley JN Autism Res; 2019 Mar; 12(3):401-421. PubMed ID: 30653853 [TBL] [Abstract][Full Text] [Related]
23. 5-aminoisoquinolinone attenuates social behavior deficits and immune abnormalities in the BTBR T Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alqahtani F; Alhoshani AR; Alasmari F; Alsaleh NB; Attia SM Pharmacol Biochem Behav; 2020 Feb; 189():172859. PubMed ID: 31982447 [TBL] [Abstract][Full Text] [Related]
24. Neonatal curcumin treatment restores hippocampal neurogenesis and improves autism-related behaviors in a mouse model of autism. Zhong H; Xiao R; Ruan R; Liu H; Li X; Cai Y; Zhao J; Fan X Psychopharmacology (Berl); 2020 Dec; 237(12):3539-3552. PubMed ID: 32803366 [TBL] [Abstract][Full Text] [Related]
25. The BTBR mouse model of autism spectrum disorders has learning and attentional impairments and alterations in acetylcholine and kynurenic acid in prefrontal cortex. McTighe SM; Neal SJ; Lin Q; Hughes ZA; Smith DG PLoS One; 2013; 8(4):e62189. PubMed ID: 23638000 [TBL] [Abstract][Full Text] [Related]
26. Renal tumours in a Tsc2(+/-) mouse model do not show feedback inhibition of Akt and are effectively prevented by rapamycin. Yang J; Kalogerou M; Samsel PA; Zhang Y; Griffiths DF; Gallacher J; Sampson JR; Shen MH Oncogene; 2015 Feb; 34(7):922-31. PubMed ID: 24632604 [TBL] [Abstract][Full Text] [Related]
27. Beneficial Effects of Early mTORC1 Inhibition after Traumatic Brain Injury. Nikolaeva I; Crowell B; Valenziano J; Meaney D; D'Arcangelo G J Neurotrauma; 2016 Jan; 33(2):183-93. PubMed ID: 26122481 [TBL] [Abstract][Full Text] [Related]
28. Somatosensorimotor and Odor Modification, Along with Serotonergic Processes Underlying the Social Deficits in BTBR T+ Itpr3 Arakawa H Neuroscience; 2020 Oct; 445():144-162. PubMed ID: 32061779 [TBL] [Abstract][Full Text] [Related]
29. Serotonin 6 receptor blockade reduces repetitive behavior in the BTBR mouse model of autism spectrum disorder. Amodeo DA; Oliver B; Pahua A; Hitchcock K; Bykowski A; Tice D; Musleh A; Ryan BC Pharmacol Biochem Behav; 2021 Jan; 200():173076. PubMed ID: 33220385 [TBL] [Abstract][Full Text] [Related]
30. AMPAKINE enhancement of social interaction in the BTBR mouse model of autism. Silverman JL; Oliver CF; Karras MN; Gastrell PT; Crawley JN Neuropharmacology; 2013 Jan; 64(1):268-82. PubMed ID: 22801296 [TBL] [Abstract][Full Text] [Related]
32. Differences in BTBR T+ tf/J and C57BL/6J mice on probabilistic reversal learning and stereotyped behaviors. Amodeo DA; Jones JH; Sweeney JA; Ragozzino ME Behav Brain Res; 2012 Feb; 227(1):64-72. PubMed ID: 22056750 [TBL] [Abstract][Full Text] [Related]
33. Maturation of nucleus accumbens synaptic transmission signals a critical period for the rescue of social deficits in a mouse model of autism spectrum disorder. Matthiesen M; Khlaifia A; Steininger CFD; Dadabhoy M; Mumtaz U; Arruda-Carvalho M Mol Brain; 2023 May; 16(1):46. PubMed ID: 37226266 [TBL] [Abstract][Full Text] [Related]
34. The adenosine A Amodeo DA; Cuevas L; Dunn JT; Sweeney JA; Ragozzino ME Autism Res; 2018 Feb; 11(2):223-233. PubMed ID: 29193861 [TBL] [Abstract][Full Text] [Related]
35. GW4064 Alters Gut Microbiota Composition and Counteracts Autism-Associated Behaviors in BTBR T+tf/J Mice. Liu J; Liu C; Gao Z; Zhou L; Gao J; Luo Y; Liu T; Fan X Front Cell Infect Microbiol; 2022; 12():911259. PubMed ID: 35811667 [TBL] [Abstract][Full Text] [Related]
36. Effects of rapamycin on social interaction deficits and gene expression in mice exposed to valproic acid in utero. Kotajima-Murakami H; Kobayashi T; Kashii H; Sato A; Hagino Y; Tanaka M; Nishito Y; Takamatsu Y; Uchino S; Ikeda K Mol Brain; 2019 Jan; 12(1):3. PubMed ID: 30621732 [TBL] [Abstract][Full Text] [Related]
37. Mammalian target of rapamycin and tuberous sclerosis complex. Wataya-Kaneda M J Dermatol Sci; 2015 Aug; 79(2):93-100. PubMed ID: 26051878 [TBL] [Abstract][Full Text] [Related]
38. Dietary interventions that reduce mTOR activity rescue autistic-like behavioral deficits in mice. Wu J; de Theije CGM; da Silva SL; Abbring S; van der Horst H; Broersen LM; Willemsen L; Kas M; Garssen J; Kraneveld AD Brain Behav Immun; 2017 Jan; 59():273-287. PubMed ID: 27640900 [TBL] [Abstract][Full Text] [Related]
39. mTOR Inhibitors in Children: Current Indications and Future Directions in Neurology. Jeong A; Wong M Curr Neurol Neurosci Rep; 2016 Dec; 16(12):102. PubMed ID: 27815691 [TBL] [Abstract][Full Text] [Related]
40. Motor and cognitive stereotypies in the BTBR T+tf/J mouse model of autism. Pearson BL; Pobbe RL; Defensor EB; Oasay L; Bolivar VJ; Blanchard DC; Blanchard RJ Genes Brain Behav; 2011 Mar; 10(2):228-35. PubMed ID: 21040460 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]